S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
BFRI$0.8899+2.28%
Biofrontera Inc.
Sector: Pharmaceutical PreparationsIndustry: Medical - PharmaceuticalsCountry: USExchange: Nasdaq
Mkt Cap:$13.22M
Float & O/S:
Inst Own:
DilutionScan read 26 of Biofrontera Inc.'s SEC filings and found 4 warrant series, 6 convertibles, 3 S-1 registrations and 1 completed offering on file for BFRI. The latest dilution event on file is a note conversion on May 11, 2026. Analysis updated Oct 5, 2026.
Signal8 Summary
Raise routes on file: effective S-1 · latest dilution event 176 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
May 11, 2026 · Note Conversion
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
2022 Purchase Warrants
Issued 2022
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
2022 Inducement Warrants
Issued 2022
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
2023 Purchase Warrants (Common Warrants)
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Senior Secured Convertible Notes due November 22, 2027
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series B-2 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series B-3 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series C Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series D Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
PIPE
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your BFRI trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
